A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration

Clinical Cancer Research

Volumn 18, Issue 7, 2012, Pages 2032-2038

  Keutgen, Xavier M ^a   Filicori, Filippo ^a   Crowley, Michael J ^a   Wang, Yongchun ^b   Scognamiglio, Theresa ^a   Hoda, Rana ^a   Buitrago, Daniel ^a   Cooper, David ^b   Zeiger, Martha A ^b   Zarnegar, Rasa ^a   Elemento, Olivier ^a   Fahey III, Thomas J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIR 146B; MIR 181; MIR 197; MIR 21; MIR 222; MIR 328; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER PROGNOSIS; COMPLETION THYROIDECTOMY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EX VIVO STUDY; FEMALE; HEMI THYROIDECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SUPPROT VECTOR MACHINE; THYROID CANCER; THYROID PARAFOLLICULAR CELL; THYROID SURGERY; THYROIDECTOMY; TUMOR VOLUME;

ADULT; AGED; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINES; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 84859375374     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-2487     Document Type: Article

References (40)

1. Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 2004;11:1093-7. (Pubitemid 40486656)
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
3. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin NorthAm1997;26:189-218. (Pubitemid 27123901)
4. Faggiano A, Caillou B, Lacroix L, Talbot M, Filetti S, Bidart JM, et al. Functional characterization of human thyroid tissue with immunohistochemistry. Thyroid 2007;17:203-11. (Pubitemid 46557367)
5. Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992;93:359-62.
6. Robertson ML, Steward DL, Gluckman JL, Welge J. Continuous laryngeal nerve integrity monitoring during thyroidectomy: does it reduce risk of injury? Otolaryngol Head Neck Surg 2004;131:596-600. (Pubitemid 39446281)
7. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
8. Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer 2007;43:1529-44. (Pubitemid 46901017)
9. Gao Y, Wang C, Shan Z, Guan H, Mao J, Fan C, et al. miRNA expression in a human papillary thyroid carcinoma cell line varies with invasiveness. Endocr J 2010;57:81-6.
10. Menon MP, Khan A. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol 2009;62:978-85.
11. Nikiforova MN, Chiosea SI, Nikiforov YE. MicroRNA expression profiles in thyroid tumors. Endocr Pathol 2009;20:85-91.
12. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005;102:19075-80. (Pubitemid 43049568)
13. Pallante P, Visone R, Croce CM, Fusco A. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 2010;17:F91-104.
14. Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW. Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 2010;102:376-82.
15. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ III, Scognamiglio T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 2008;21:1139-46.
16. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE. Micro-RNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 2008;93:1600-8. (Pubitemid 351656494)
17. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 2006;13:497-508. (Pubitemid 43886672)
18. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007;14:791-8. (Pubitemid 350074067)
19. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 2006;91:3584-91. (Pubitemid 44402141)
20. Duda R, Hart PE, Stork DG. Pattern classification. 2nd ed. New York: Wiley-Interscience; 2000.
21. Venables W, Ripley BD. Modern applied statistics with S (statistics and computing). 4th ed. New York: Springer; 2010.
22. Gharib H. Changing trends in thyroid practice: understanding nodular thyroid disease. Endocr Pract 2004;10:31-9.
23. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-71.
24. Layfield LJ, Cibas ES, Baloch Z. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium. Cytopathology 2010;21:75-85.
25. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009;94:2092-8.
26. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 2009;27:2977-82.
27. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009;19:1351-61.
28. Eszlinger M, Paschke R. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol 2010;322:29-37.
29. Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf) 2007;66:678-83. (Pubitemid 46699541)
30. Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, et al. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol 2009;161:467-73.
31. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 2005;242:353-61; discussion 361-3.
32. Kebebew E, Peng M, Reiff E, McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 2006;106:2592-7.
33. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, et al. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 2003;9:1792-800. (Pubitemid 36554606)
34. Prasad NB, Somervell H, Tufano RP, Dackiw AP, Marohn MR, Califano JA, et al. Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res 2008; 14:3327-37.
35. Finley DJ, Lubitz CC, Wei C, Zhu B, Fahey TJ III. Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling. Thyroid 2005;15:562-8. (Pubitemid 40993729)
36. Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, et al. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 2004;64:2898-903. (Pubitemid 38500631)
37. Mazeh H, Mizrahi I, Halle D, Ilyayev N, Stojadinovic A, Trink B, et al. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 2011;21:111-8.
38. Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, et al. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol 2011;18:3443-52.
39. Frezzetti D, Menna MD, Zoppoli P, Guerra C, Ferraro A, Bello AM, et al. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 2010;30:275-86.
40. Jazdzewski K, Boguslawska J, Jendrzejewski J, Liyanarachchi S, Pachucki J, Wardyn KA, et al. Thyroid hormone receptor {beta} (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). J Clin Endocrinol Metab 2010;96: E546-53.